Recent News

By Region: North America

The Future of the U.S.-South Africa HIV/AIDS Partnership

(CSIS) South Africa has the highest burden of HIV/AIDS in the world, with 5.6 million people living with the virus and over 400,000 newly infected annually. Since 2004, the U.S. government has committed more than $4 billion to combating HIV/AIDS in South Africa—the largest U.S. investment in HIV/AIDS worldwide. Continued progress in controlling HIV/AIDS in Read More »

March 15, 2013
| Filed under Africa, North America, Policy & Initiatives, and Public Health
Share

Researchers advance fight against leading infectious cause of congenital birth defects

(EurekAlert) A virus most people probably have never heard of, but that the majority of us carry, is the No. 1 infectious cause of congenital birth defects in the U.S. today. Because of cytomegalovirus (CMV) infection during in utero development, 1 in 750 children are born with or develop permanent disabilities such as hearing loss Read More »

March 14, 2013
| Filed under North America and Research
Share

The Deadly Virus That’s Spreading Faster Than Malaria or West Nile

(TakePart) About half of the world is at risk of a virus that Americans don’t know at all. For Americans, dengue fever is about as foreign as the metric system or the leading contenders in next year’s World Cup. But while we don’t know much about it, for the rest of the world, dengue is Read More »

March 14, 2013
| Filed under North America and Public Health
Share

Aeolus Provides Investor Update on Passage of Pandemic All-Hazards Preparedness Act of 2013

(Marketwire) Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of novel compounds to protect against radiological and chemical threats and for use in oncology, provided an update to investors on the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA). The bill was signed into law today Read More »

March 14, 2013
| Filed under North America, Biotechnology, and Policy & Initiatives
Share

JPM-TMT Seeks Solutions to Multi-Drug Resistant Biowarfare Agents

(GlobalBiodefense) The U.S. Department of Defense has initiated a new research and development effort to address the continuing emergence of multi-drug resistant bacteria and advancements in biotechnology that enable development of genetically engineered, drug-resistant bacteria. To address the potential weaponization of multi-drug resistant biological warfare agents the Joint Project Manager Transformational Medical Technologies (JPM-TMT) has Read More »